Regenersis appoints Dr Frank Blin to its Board as Senior Independent Director

– UK – Regenersis plc (AIM: RGS), a strategic outsourcing partner to many of the world’s leading consumer technology companies, is pleased to announce that Dr Frank Blin CBE has been appointed to the Board as a Non-Executive Director and Senior Independent Director with immediate effect.  Frank has also been appointed Chairman of the Audit Committee and a member of the Remuneration Committee with immediate effect.

Frank, aged 60, enjoyed a long and successful career with PwC, becoming Head of UK Regions and a UK Management Board member before his retirement in 2012. He was awarded a CBE for his services to the Scottish financial sector in 2002 and was awarded an honorary Doctorate of Business Administration by the University of Strathclyde in 2010.

Matthew Peacock, Chairman, said: “I am delighted to welcome Frank to the Board. He brings a wealth of transaction and board experience working with growth businesses. We look forward to his contribution and working with him.”

About Regenersis Plc

Regenersis provides a suite of product life cycle support services designed to help companies and their customers successfully deploy, protect, sustain, retire and re-use digital technology. 

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.